Atlas Trials

Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer

Clinical trial NCT05933980 · UNKNOWN

Trial details

NCT number
NCT05933980
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal CancerLiver MetastasesMSS
Start date
2023-12-19
Primary completion
2025-09-20
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.